Vol 14: Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim.Report as inadecuate



 Vol 14: Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim.


Vol 14: Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 14: Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim.
This article is from BMC Cancer, volume 14.AbstractBackground: A common approach to cancer therapy in clinical practice is the combination of several drugs to boost the anticancer activity of available drugs while suppressing their unwanted side effects. In this regard, we examined the efficacy of combination treatment with the widely-used genotoxi

Author: Park, Hye-Kyung; Lee, Ji-Eun; Lim, Jaehwa; Jo, Da-Eun; Park, Soo-Ah; Suh, Pann-Ghill; Kang, Byoung Heon

Source: https://archive.org/







Related documents